(S)-1-(3-(叔丁基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯-4-基)-2,5-二苯基-1H-吡咯, 98%

(S)-1-(3-(Tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-4-yl)-2,5-diphenyl-1H-pyrrole

三丁基(乙基)鏻二乙基膦酸盐, ≥96%

Tributyl(ethyl)phosphonium Diethyl Phosphate

[四丁基铵][Δ-三(四氯-1,2-苯二醇酸根)磷酸盐(V)], ≥98.5%

Δ-TRISPHAT Delta-TRISPHAT tetrabutylammonium salt 

[S(R)]-N-[(1S)-2-(二苯基膦)-1-苯基乙基]-N-甲基-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(1S)-2-(Diphenylphosphino)-1-phenylethyl]-N,2-dimethyl-2-propanesulfinamide

[S(R)]-N-[(S)-[2-(二环己基膦)苯基]-2-萘基甲基]-N-甲基-2-叔丁基亚磺酰胺, ≥98%

[S(R)]-N-[(S)-[2-(Dicyclohexylphosphino)phenyl]-2-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide

(R)-(-)-1-氨基-2,3-二氢茚, 99%

(R)-(-)-1-Aminoindane

二甲基二苯基碘化鏻, 98%

Dimethyldiphenylphosphonium iodide

(1S,2S)-N-Cbz-环己氨基醇, ≥99%,≥99.9% e.e.

[(1S,2S)-2-Hydroxycyclohexyl]carbamic Acid Phenylmethyl Ester

(11BR)-N-甲基-N-[(R)-1-苯基乙基]-联萘并[2,1-D:1',2'-F][1,3,2]二氧膦杂-4-胺, 98%

R-N-Methyl-N-[(1R)-1-phenylethyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-aMine

[S(R)]-N-[(R)-(3,5-双叔丁基-4-甲氧基苯基)[2-(二苯基膦)苯基]甲基]-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(R)-[3,5-Bis(1,1-dimethylethyl)-4-methoxyphenyl][2-(diphenylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide

[S(R)]-N-[(S)-[2-(二苯基膦)-4,5-二甲氧基苯基]-1-萘基甲基]-2-叔丁基亚磺酰胺

[S(R)]-N-[(S)-[2-(Diphenylphosphino)-4,5-dimethoxyphenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide

≥98%

[S(R)]-N-[(S)-[3,5-二叔丁基-4-甲氧基苯基][(3-苄氧基-2-(二环己基膦)苯基)甲基]-2-叔丁基亚磺酰胺, ≥98%

[S(R)]-N-[(S)-[3,5-Di-tert-butyl-4-methoxyphenyl][(3-benzyloxy-2-(dicyclohexylphosphino)phenyl)methyl]-2-methyl-2-propanesulfinamide

二甲基氧化膦, 98%

Dimethylphosphine oxide

（2S，3R）-3-（叔丁基）-2-（二叔丁基膦基）-4-甲氧基-2,3-二氢苯并[d] [1,3]氧杂磷杂戊环

N-methyl-N-((3R,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine(1:1)

98%,>99.9% ee

(1S,2S)-N-乙酰基环己氨基醇, ≥99%,≥99.9% e.e.

N-[(1S,2S)-2-Hydroxycyclohexyl]acetamide

三丁基乙基溴化膦, ≥99.9%

Ethyltributylphosphonium Bromide

[S(R)]-N-[(R)-[2-(二苯基膦)苯基](4-甲氧基苯基)甲基]-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide

(11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

（4S，5R）-3，3a，8，8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯

(4S,5R)-3,3a,8,8a-Tetrahydroindeno[1,2-d]-1,2,3-oxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester

≥98%

[S(R)]-N-[(R)-[2-(二苯基膦)苯基](4-甲氧基苯基)甲基]-N-甲基-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-N,2-dimethyl-2-propanesulfinamide